{"schema_version":"secwatch.filing_event.v1","accession":"0001708599-25-000005","form_type":"8-K","ticker":"SER","cik":"0001708599","company_name":"Serina Therapeutics, Inc.","filed_at":"2025-01-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.529009+00:00","generated_at":"2026-05-28T01:12:54.292143+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Serina Therapeutics appoints Karen J. Wilson to board; Steven Mintz departs","bullets":["Karen J. Wilson appointed effective Jan 14, 2025; over 30 years life sciences finance experience, CPA.","Wilson will serve as Compensation Committee Chair and on the Audit Committee.","Steven Mintz departs board; no disagreement; Remy Gross replaces as Audit Committee chair.","Wilson also serves on boards of Connect Biopharma, Elicio Therapeutics, and LAVA Therapeutics."],"urls":{"canonical":"https://secwatch.observer/filing/0001708599-25-000005","json":"https://secwatch.observer/filing/0001708599-25-000005.json","markdown":"https://secwatch.observer/filing/0001708599-25-000005.md","text":"https://secwatch.observer/filing/0001708599-25-000005.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1708599/000170859925000005/0001708599-25-000005-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1708599/000170859925000005/ser-20250114.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T01:12:54.292143+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2b52dc4d3f","claim":"Steven Mintz departed as Director at Serina Therapeutics, Inc..","evidence_excerpt":"departure of Steven Mintz from its Board of Directors","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1708599/000170859925000005/0001708599-25-000005-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"departed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"fb6b1b3747","claim":"Karen J. Wilson was appointed as Director at Serina Therapeutics, Inc..","evidence_excerpt":"appointment of Karen J. Wilson to the Company’s Board of Directors, effective January 14, 2025","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1708599/000170859925000005/0001708599-25-000005-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}